Pig kidney transplant trial offers hope for patients out of options
NCT ID NCT06878560
Summary
This study is testing the safety and effectiveness of transplanting a kidney from a genetically modified pig into people with end-stage kidney disease. It is for patients who are either not eligible for a standard human kidney transplant or are on the waiting list but are unlikely to receive one in time. Researchers will monitor how well the transplanted kidney works and the patient's health for 24 weeks, followed by lifelong follow-up.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York University Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.